PDCD1 and neoplasm: By contrast, the response to anti-PD-1 therapy, alone or sequentially combined with cisplatin, was paradoxical, and led to an increase in tumor growth rate (in the anti-PD-1 phase) with large and friable tumors in some cases, which were associated with exudates containing inflammatory PMNs from areas of reactive necrosis.